# Anteris Technologies Global Corp. (AVR) fundamentals

Data as of 2026-11-04. NASDAQ, United States. Sector: Healthcare / Medical Devices & Supplies. Price $5.60, market value $546 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Anteris Technologies Global Corp. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 243.4×**. Each dollar of revenue is priced at 243.4×, a level that requires very high margins or very fast growth to justify.
- **Free-cash-flow yield: -16.2%** (5-yr avg -49.7%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Return on assets: -450.3%**. Each dollar of assets produces -450.3% of profit.

## Growth
- **Revenue growth (1 yr): -29.2%**. Revenue fell 29.2% over the last year.
- **EPS growth (1 yr): 30.7%**. Earnings per share rose 30.7%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Net debt / EBITDA: 0.1×**. It would take 0.1 years of operating earnings to repay net borrowings, within the comfortable range.
- **Current ratio: 0.73** (quick 0.73). Current liabilities exceed current assets, so the company depends on ongoing cash generation or refinancing to pay the next year's bills.
- **Altman Z-score: 0.39**. A Z-score of 0.39 is in the distress zone, a signal to examine the balance sheet closely.
- **Piotroski F-score: 2/9**. 2 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. Anteris Technologies Global Corp. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: strong_buy** (4 analysts). 4 analysts cover Anteris Technologies Global Corp.; the consensus is strong_buy, with an average price target of $14.00 (+150% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 28.7%** (YTD 15.8%, 3-mo -30.2%). The shares are up 28.7% over twelve months including dividends.
- **From 52-week high: -49.3%** (69.7% above the low). Trading 49% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 33**. An RSI of 33 is neutral.
- **Beta (1 yr): 1.43** (volatility 62%). Beta of 1.43 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=AVR · Page: https://foliofundamentals.com/stocks/avr

Not investment advice.